Segment Information

9 Months Ended

Jun. 30, 2012

Segment Information [Abstract]

Segment Information

(13)Segment Information

In connection with the acquisition of IZI during the first quarter of fiscal 2012, the Company began to operate in three reportable segments, Radiation Measurement (formerly Monitoring), Medical Physics and Medical Products.The factors for determining the reportable segments reflect specific markets and the products and services offered combined with the nature of the individual business traits, as well as key financial information reviewed by management.During the third quarter of fiscal 2012, management determined that Radiation Measurement was a more accurate description for Landauer’s expanded portfolio of activities that focus on assessing radiation dose through radiation measurement and monitoring services and the provision of instrumentation for use by medical, research, military and nuclear fuel cycle markets.The Radiation Measurement segment comprises the metrological activities of the business.

The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure.These services are provided primarily to hospitals, medical and dental offices, universities, national laboratories, and nuclear facilities.Radiation Measurement activities also include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings.In addition to providing analytical services, the Radiation Measurement segment leases or sells dosimetry detectors and reading equipment.

The Medical Physics segment provides therapeutic and imaging physics services to domestic hospitals, free standing imaging centers and radiation therapy centers.Service offerings include clinical physics support, equipment commissioning, accreditation support and imaging equipment testing.These professional services are provided to customers on-site by skilled physicists.

The Medical Products segment provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures. Medical products range from consumables used with MRI, CT, and mammography technologies to highly engineered passive reflective markers used during image guided surgery procedures.Medical Products sales are provided through the Company’s IZI subsidiary.

The Company primarily evaluates performance of the individual segments based upon, among other metrics, segment operating income or loss.Segment operating income or loss is segment revenues less segment cost of sales and segment selling, general and administrative expenses.Corporate expenses for shared functions, including corporate management, corporate finance and human resources, are recognized in the Radiation Measurement segment where they have been reported historically.In addition, acquisition and reorganization costs are not allocated to the segments.Information about net other income, including interest income and expense, and income taxes is not provided at the segment level. As the Company’s business model evolves in increased complexity, management may determine it necessary to change this reporting practice to reflect any appropriate allocations.

The following tables summarize financial information for each reportable segment:

			Three Months Ended June 30, 2012
	Radiation Measurement			Medical Physics		Medical Products		Consolidated
Revenues	$	26,926		$	8,064	$	4,215	$	39,205
Operating income		6,813			517		1,919		9,249
Depreciation and amortization		1,803			395		524		2,722
Capital expenditures for property, plant & equipment		3,949			137		32		4,118

			Three Months Ended June 30, 2011
	Radiation Measurement			Medical Physics		Medical Products		Consolidated
Revenues	$	23,860		$	5,298	$	0	$	29,158
Operating income		7,790			42		0		7,832
Depreciation and amortization		1,905			241		0		2,146
Capital expenditures for property, plant & equipment		3,786			188		0		3,974

			Nine Months Ended June 30, 2012
	Radiation Measurement			Medical Physics		Medical Products		Consolidated
Revenues	$	81,328		$	23,186	$	10,454	$	114,968
Operating income		21,132			1,519		4,300		26,951
Depreciation and amortization		5,415			1,029		1,308		7,752
Capital expenditures for property, plant & equipment		10,986			449		41		11,476

			Nine Months Ended June 30, 2011
	Radiation Measurement			Medical Physics		Medical Products		Consolidated
Revenues	$	75,291		$	14,632	$	0	$	89,923
Operating income (loss)		28,449			(610)		0		27,839
Depreciation and amortization		5,077			673		0		5,750
Capital expenditures for property, plant & equipment		9,152			475		0		9,627

	June 30, 2012		September 30, 2011
Segment Assets:
Radiation Measurement	$	153,493	$	136,950
Medical Physics		37,571		31,706
Medical Products		95,184		0
Consolidated Assets	$	286,248	$	168,656